Neuroprotective Strategies during Cardiac Surgery with Cardiopulmonary Bypass

Int J Mol Sci. 2016 Nov 21;17(11):1945. doi: 10.3390/ijms17111945.

Abstract

Aortocoronary bypass or valve surgery usually require cardiac arrest using cardioplegic solutions. Although, in principle, in a number of cases beating heart surgery (so-called off-pump technique) is possible, aortic or valve surgery or correction of congenital heart diseases mostly require cardiopulmonary arrest. During this condition, the heart-lung machine also named cardiopulmonary bypass (CPB) has to take over the circulation. It is noteworthy that the invention of a machine bypassing the heart and lungs enabled complex cardiac operations, but possible negative effects of the CPB on other organs, especially the brain, cannot be neglected. Thus, neuroprotection during CPB is still a matter of great interest. In this review, we will describe the impact of CPB on the brain and focus on pharmacological and non-pharmacological strategies to protect the brain.

Keywords: cardiopulmonary bypass; heart-lung machine; neuroprotection.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Antioxidants / therapeutic use
  • Aorta / drug effects
  • Aorta / pathology
  • Aorta / surgery
  • Brain / blood supply
  • Brain / drug effects*
  • Brain Edema / prevention & control*
  • Cardiac Surgical Procedures / methods*
  • Cardiopulmonary Bypass / methods*
  • Cognitive Dysfunction / prevention & control*
  • Heart / drug effects
  • Heart Arrest / chemically induced
  • Heart Arrest / surgery*
  • Heart Arrest / therapy
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Hypothermia, Induced
  • Lung / blood supply
  • Lung / drug effects
  • Lung / surgery
  • Neuroprotective Agents / therapeutic use*
  • Pulsatile Flow
  • Vasodilator Agents / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Hypoglycemic Agents
  • Neuroprotective Agents
  • Vasodilator Agents